Home  /  Resource Library  /  Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma

Clinical outcomes of CD3xCD20 bispecific antibodies in patients with central nervous system involvement by lymphoma

Results of a stud investigating bispecifics for treatment of central nervous system lymphomas.